San Francisco, California, October 24, 2018 – The kidney stones management market is increasingly benefitting from the growing number of minimally-invasive surgeries for treating kidney stones and advancement in related imaging modalities, notably in ureteroscope. The alarming recurrence rate of urolithiasis observed in worldwide patient populations and the substantial morbidities the disease has are factors bolstering the demand for better kidney stones management.
A critical assessment of such trends and evaluation of impacts on the growth trajectories of the market are offered in a report by TMR Research. The study is titled “Kidney Stones Management Market – Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2018–2028”.
Get Sample Copy of this Report @
The rising prevalence of kidney stones is favorably impacting the growth of the market. Over the past few years, several less invasive treatments have emerged in the healthcare sector which maximizes stone clearance and minimizes the morbidity in patients. Furthermore, substantial advances in medical management of renal stones has created new avenues in recent years. This has led to vast improvement in approaches in treatment of proximal and intra-renal kidney stones. The growing acceptance of percutaneous nephrolithotomy as advanced treatment for nephrolithiasis is a notable factor fueling the evolution of market.
However, the lack of awareness of the morbidity of kidney is a crucial factor crippling the expansion of the kidney stones management market. The problem is accentuated by the marked reluctance of a chunk of patient population in some countries to undergo standard metabolic evaluation. Nevertheless, research and development to expand the understanding the pathogenesis of stone disease and the growing focus on individualization of treatment for patients augur well for the market.
Read Comprehensive Overview of Report @
Developed markets such as the U.S. and few countries in Europe are likely to benefit from the adoption of advanced treatments and better medical evaluations for the management of kidney stones. The rising incidence kidney stones in emerging economies such as in Asia Pacific points to large unmet needs, thereby boosting the overall market.
Some of the prominent players in the kidney stones management market are Elmed Medical Systems, Karl Storz SE & Co. KG, Cook Medical, Boston Scientific, Richard Wolf GmbH, and C. R. Versifier.